(0.35%) 5 117.58 points
(0.34%) 38 370 points
(0.42%) 15 994 points
(-1.18%) $82.86
(5.51%) $2.03
(0.41%) $2 356.80
(0.39%) $27.64
(4.56%) $964.15
(-0.25%) $0.932
(-0.41%) $10.98
(-0.58%) $0.796
(1.68%) $93.42
1.01% $ 7.44
Live Chart Being Loaded With Signals
Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments...
Stats | |
---|---|
Tagesvolumen | 252 546 |
Durchschnittsvolumen | 2.07M |
Marktkapitalisierung | 29.25B |
EPS | $0 ( 2024-03-05 ) |
Nächstes Ertragsdatum | ( $0 ) 2024-05-09 |
Last Dividend | $0.632 ( 2023-05-02 ) |
Next Dividend | $0 ( N/A ) |
P/E | -9.30 |
ATR14 | $0.00700 (0.09%) |
Volumen Korrelation
Bayer Aktiengesellschaft Korrelation
10 Am meisten positiv korreliert |
---|
10 Am meisten negativ korreliert |
---|
Wussten Sie das?
Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).
Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.
Bayer Aktiengesellschaft Korrelation - Währung/Rohstoff
Bayer Aktiengesellschaft Finanzdaten
Annual | 2023 |
Umsatz: | $47.64B |
Bruttogewinn: | $27.89B (58.54 %) |
EPS: | $-2.99 |
FY | 2023 |
Umsatz: | $47.64B |
Bruttogewinn: | $27.89B (58.54 %) |
EPS: | $-2.99 |
FY | 2022 |
Umsatz: | $50.74B |
Bruttogewinn: | $30.87B (60.84 %) |
EPS: | $4.22 |
Financial Reports:
No articles found.
Bayer Aktiengesellschaft Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0.632 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.320 | 2001-04-25 |
Last Dividend | $0.632 | 2023-05-02 |
Next Dividend | $0 | N/A |
Payout Date | 2023-05-15 | |
Next Payout Date | N/A | |
# dividends | 24 | -- |
Total Paid Out | $12.19 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 1.58 | -- |
Div. Sustainability Score | 3.23 | |
Div.Growth Potential Score | 2.39 | |
Div. Directional Score | 2.81 | -- |
Year | Amount | Yield |
---|
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
WJRYF | Ex Dividend Knight | 2023-09-28 | Annually | 0 | 0.00% | |
MCBK | Ex Dividend Junior | 2023-05-02 | Annually | 0 | 0.00% | |
CMSQY | Ex Dividend Knight | 2023-08-22 | Annually | 0 | 0.00% | |
SOBS | Ex Dividend Knight | 2023-06-29 | Quarterly | 0 | 0.00% | |
HCMLY | Ex Dividend Knight | 2023-05-09 | Annually | 0 | 0.00% | |
AMNF | Ex Dividend King | 2023-07-06 | Quarterly | 0 | 0.00% | |
NLCP | Ex Dividend Knight | 2023-09-28 | Quarterly | 0 | 0.00% | |
CTUY | Ex Dividend Junior | 2023-05-24 | Annually | 0 | 0.00% | |
THNPF | Ex Dividend Knight | 2023-05-22 | Annually | 0 | 0.00% | |
IDCBY | Ex Dividend Junior | 2023-07-06 | Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | -0.0617 | 1.500 | -1.235 | -1.852 | [0 - 0.5] |
returnOnAssetsTTM | -0.0238 | 1.200 | -0.795 | -0.954 | [0 - 0.3] |
returnOnEquityTTM | -0.0816 | 1.500 | -2.02 | -3.03 | [0.1 - 1] |
payoutRatioTTM | -0.809 | -1.000 | -8.09 | 8.09 | [0 - 1] |
currentRatioTTM | 1.259 | 0.800 | 8.70 | 6.96 | [1 - 3] |
quickRatioTTM | 0.784 | 0.800 | -0.0946 | -0.0757 | [0.8 - 2.5] |
cashRatioTTM | 0.201 | 1.500 | 10.00 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.355 | -1.500 | 4.08 | -6.11 | [0 - 0.6] |
interestCoverageTTM | 0.595 | 1.000 | -0.891 | -0.891 | [3 - 30] |
operatingCashFlowPerShareTTM | 4.85 | 2.00 | 8.38 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 2.05 | 2.00 | 8.97 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 1.332 | -1.500 | 4.67 | -7.01 | [0 - 2.5] |
grossProfitMarginTTM | 0.585 | 1.000 | 3.58 | 3.58 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0333 | 1.000 | -1.333 | -1.333 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.109 | 1.000 | -0.507 | -0.507 | [0.2 - 2] |
assetTurnoverTTM | 0.386 | 0.800 | -0.759 | -0.607 | [0.5 - 2] |
Total Score | 3.23 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -2.30 | 1.000 | -0.333 | 0 | [1 - 100] |
returnOnEquityTTM | -0.0816 | 2.50 | -1.297 | -3.03 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 2.05 | 2.00 | 9.32 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 9.49 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 4.85 | 2.00 | 8.38 | 10.00 | [0 - 30] |
payoutRatioTTM | -0.809 | 1.500 | -8.09 | 8.09 | [0 - 1] |
pegRatioTTM | 0.243 | 1.500 | -1.711 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.100 | 1.000 | 10.00 | 0 | [0.1 - 0.5] |
Total Score | 2.39 |
Bayer Aktiengesellschaft
Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, medicated skincare products, nutritional supplements, and self-care solutions in dermatology, nutritional supplements, pain and cardiovascular risk prevention, digestive health, allergy, and cold and cough. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solution, and pest and weed control products, as well as customer service for agriculture. This segment also provides breeding, propagation, and production/processing of seeds, including seed dressing. The company has a collaboration agreement with MD Anderson Cancer Center to develop oncology drugs; research and license agreement with Dewpoint Therapeutics, Inc. for the development of new treatments for cardiovascular and gynecological diseases; collaboration agreement with Exscientia Ltd, Foundation Medicine Inc., and Evotec AG; research collaboration with Arvinas Inc.; strategic research partnership with University of Oxford to develop novel gynecological therapies; and Kyoto University to identify new drugs candidates for the treatment of pulmonary diseases. It distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. Bayer Aktiengesellschaft was founded in 1863 and is headquartered in Leverkusen, Germany.
Über Live-Signale
Die Live-Signale auf dieser Seite helfen dabei zu bestimmen, wann man NA kaufen oder verkaufen soll. Die Signale haben eine Verzögerung von bis zu 1 Minute; wie bei allen Marktsignalen besteht die Möglichkeit von Fehlern oder Fehleinschätzungen.
Die Live-Handelssignale sind nicht endgültig und getagraph.com übernimmt keine Verantwortung für Maßnahmen, die aufgrund dieser Signale ergriffen werden, wie in den Nutzungsbedingungen beschrieben. Die Signale basieren auf einer breiten Palette von technischen Analyseindikatoren.